neutral
Recently
P&G and Sanofi headline key Q3 earnings session
No Image
Procter & Gamble and Sanofi headline Q3 reports, with investors monitoring consumer and healthcare earnings amid stable inflation expectations and resilient spending trends.
Procter & Gamble forecast Q3 earnings per share at $1.90, a 1.5% yearly decline, while Sanofi expected $1.60 EPS, up 1.9% year-on-year. HCA Healthcare and Gentex were also scheduled to report as U.S. corporates neared the final week of Q3 results. Analysts tracked consumer staples and healthcare trends for inflation impact and margin recovery signs. Broader sentiment remained positive amid steady economic growth outlook and resilient household spending patterns in major markets.